Is today’s pharmaceutical commercial model going extinct?
Novel cell and gene therapy options are significantly improving treatment outcomes, and in some cases providing cures via one-time treatment to rare diseases...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Jessica Nozzi is an associate principal in the Life Sciences Practice of Charles River Associates. She has worked on a variety of strategy projects for leading pharmaceutical and biotechnology companies across many therapeutic areas, including extensive experience in rare disease. Her focus has largely been on market research, brand strategy, launch planning, and market access.